84 related articles for article (PubMed ID: 6547096)
1. Comparison of CFU-GM response to piperazinedione versus cyclophosphamide in normal mice.
OKunewick JP; Buffo MJ; Kociban DL
Exp Hematol; 1984 Jun; 12(5):297-300. PubMed ID: 6547096
[TBL] [Abstract][Full Text] [Related]
2. Comparative toxicity of mitoxantrone and doxorubicin on hematopoietic stem cells.
OKunewick JP; Buffo MJ; Kociban DL
Exp Hematol; 1985; 13 Suppl 16():23-30. PubMed ID: 3987836
[TBL] [Abstract][Full Text] [Related]
3. In vivo effects of indomethacin and cyclophosphamide on CFU-GM proliferation and cyclic nucleotide levels in bone marrow of mice.
Fontagne J; Bertin R; de Marco F; Zizine L; Adolphe M; Portet R; Lechat P
Biomed Pharmacother; 1983; 37(9-10):452-7. PubMed ID: 6326884
[TBL] [Abstract][Full Text] [Related]
4. [The effect of NGF on hematopoiesis of granulocyte-macrophage in normal and radiation, chemistry injury mice].
Huang XQ; Zhu BD; Jiang-Yang-ze-ren
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):757-62. PubMed ID: 19024307
[TBL] [Abstract][Full Text] [Related]
5. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
[TBL] [Abstract][Full Text] [Related]
6. Effects of cyclophosphamide on murine bone marrow and splenic megakaryocyte-CFC, granulocyte-macrophage-CFC, and peripheral blood cell levels.
Yeager AM; Levin FC; Levin J
J Cell Physiol; 1982 Aug; 112(2):222-8. PubMed ID: 7119022
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of stem cell factor with interleukin-3 or granulocyte-macrophage colony-stimulating factor on the proliferation of murine primitive hematopoietic progenitors.
Wu DD; Nayar R; Keating A
Exp Hematol; 1994 Jun; 22(6):495-500. PubMed ID: 7514543
[TBL] [Abstract][Full Text] [Related]
8. A new experimental protocol as an alternative to the colony-forming unit-granulocyte/macrophage (CFU-GM) clonogenic assay to assess the haematotoxic potential of new drugs.
Dal Negro G; Vandin L; Bonato M; Repeto P; Sciuscio D
Toxicol In Vitro; 2006 Aug; 20(5):750-6. PubMed ID: 16321498
[TBL] [Abstract][Full Text] [Related]
9. Combined interleukin-1 beta/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression.
Tritarelli E; Greco G; Testa U; Belardelli F; Peschle C; Proietti E
Cancer Res; 1994 Dec; 54(24):6469-76. PubMed ID: 7987845
[TBL] [Abstract][Full Text] [Related]
10. Effect of recombinant human granulocyte colony-stimulating factor on variations of morphologically identifiable bone marrow cells in myelosuppressed mice.
Kabaya K; Kusaka M; Seki M
In Vivo; 1994; 8(6):1033-9. PubMed ID: 7539636
[TBL] [Abstract][Full Text] [Related]
11. In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation.
Lopez M; Mary JY; Sainteny F
Exp Hematol; 1993 Feb; 21(2):311-8. PubMed ID: 8425567
[TBL] [Abstract][Full Text] [Related]
12. Toward refinement of the colony-forming unit-granulocyte/macrophage clonogenic assay: inclusion of a metabolic system.
Dal Negro G; Vandin L; Bonato M; Sciuscio D
Toxicol In Vitro; 2006 Aug; 20(5):743-9. PubMed ID: 16324821
[TBL] [Abstract][Full Text] [Related]
13. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
14. Effect of two cyclophosphamide derivatives on hemopoietic progenitor cells and pluripotential stem cells.
Porcellini A; Manna A; Talevi N; Sparaventi G; Marchetti-Rossi MT; Baronciani D; De Biagi M
Exp Hematol; 1984 Dec; 12(11):863-6. PubMed ID: 6510485
[TBL] [Abstract][Full Text] [Related]
15. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
[TBL] [Abstract][Full Text] [Related]
16. Influence of rhG-CSF scheduling on megakaryocytopoietic recovery following 5-fluorouracil-induced hematotoxicity in splenectomized B6D2F1 mice.
Scheding S; Media JE; Nakeff A
Stem Cells; 1998; 16(2):144-51. PubMed ID: 9554039
[TBL] [Abstract][Full Text] [Related]
17. Megakaryocytopoiesis and granulopoiesis following cyclophosphamide.
Petursson SR; Chervenick PA
J Lab Clin Med; 1982 Nov; 100(5):682-94. PubMed ID: 7130827
[TBL] [Abstract][Full Text] [Related]
18. IL-4 promotes macrophage development by rapidly stimulating lineage restriction of bipotent granulocyte-macrophage colony-forming cells.
Nicholls SE; Heyworth CM; Dexter TM; Lord JM; Johnson GD; Whetton AD
J Immunol; 1995 Jul; 155(2):845-53. PubMed ID: 7608562
[TBL] [Abstract][Full Text] [Related]
19. Clonal analysis of progenitor cell commitment of granulocyte or macrophage production.
Metcalf D; Burgess AW
J Cell Physiol; 1982 Jun; 111(3):275-83. PubMed ID: 6980223
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.
Patchen ML; Vaudrain T; Correira H; Martin T; Reese D
Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
